Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Aug 8, 2025
- Accession no.
- 0001562180-25-005691
- Filed
- Aug 8, 2025
- Trade date
- Aug 7, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.30M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & GENERAL COUNSEL) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | Common Stock | MOption exerciseAcquired | +11,000 | $135.42 | +$1,489,620 | 47,781 | Direct | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −1,391 | $297.49F2 | −$413,808.59 | 46,390 | Direct | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −1,353 | $298.73F3 | −$404,181.69 | 45,037 | Direct | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −2,918 | $299.48F4 | −$873,882.64 | 42,119 | Direct | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −2,837 | $300.47F5 | −$852,433.39 | 39,282 | Direct | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −1,401 | $301.67F6 | −$422,639.67 | 37,881 | Direct | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −1,000 | $302.70F7 | −$302,700 | 36,881 | Direct | |
| Aug 7, 2025 | Common Stock | SSaleDisposed | −100 | $303.45 | −$30,345 | 36,781 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | Common Stock | MOption exerciseDisposed | −11,000 | $0.00 | $0 | 88,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $297.04 to $298.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $298.04 to $299.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $299.06 to $300.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $300.10 to $300.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $301.18 to $302.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $302.19 to $303.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.